PATEL DINESH V PH D — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

PATEL DINESH V PH D has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $35.58M.

Profile

PATEL DINESH V PH D

Dinesh V. Patel, Ph.D., is the President and CEO of Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing peptide-based drug candidates. He has extensive experience in the biopharmaceutical industry and has held various leadership roles throughout his career.

RolePresident and CEO, Director
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-15PTGXProtagonist Therapeutics, IncS — Open-market sale75.0K$100.12$7.51M
2026-05-15PTGXProtagonist Therapeutics, IncM — Option exercise75.0K$21.58$1.62M
2026-05-12PTGXProtagonist Therapeutics, IncS — Open-market sale75.0K$100.12$7.51M
2026-05-12PTGXProtagonist Therapeutics, IncM — Option exercise75.0K$21.58$1.62M
2026-04-24PTGXProtagonist Therapeutics, IncG — Bona-fide gift1.5K$0.00
2026-03-25PTGXProtagonist Therapeutics, IncS — Open-market sale54.6K$101.00$5.52M
2026-03-25PTGXProtagonist Therapeutics, IncM — Option exercise54.6K$8.58$469K
2026-03-25PTGXProtagonist Therapeutics, IncS — Open-market sale59$101.00$6K
2026-03-25PTGXProtagonist Therapeutics, IncM — Option exercise59$8.58$506
2026-03-25PTGXProtagonist Therapeutics, IncG — Bona-fide gift50.0K$0.00
2026-01-28PTGXProtagonist Therapeutics, IncS — Open-market sale4.1K$83.19$338K
2026-01-28PTGXProtagonist Therapeutics, IncM — Option exercise4.1K$21.58$88K
2026-01-28PTGXProtagonist Therapeutics, IncS — Open-market sale14.2K$84.05$1.19M
2026-01-28PTGXProtagonist Therapeutics, IncM — Option exercise14.2K$21.58$307K
2026-01-28PTGXProtagonist Therapeutics, IncS — Open-market sale10.7K$84.00$898K
2026-01-28PTGXProtagonist Therapeutics, IncM — Option exercise10.7K$4.21$45K
2026-01-28PTGXProtagonist Therapeutics, IncS — Open-market sale19.3K$84.59$1.63M
2026-01-28PTGXProtagonist Therapeutics, IncM — Option exercise19.3K$4.21$81K
2026-01-28PTGXProtagonist Therapeutics, IncG — Bona-fide gift6.0K$0.00
2026-01-21PTGXProtagonist Therapeutics, IncS — Open-market sale34.4K$82.48$2.84M

Companies — Last 90 Days

Frequently Asked Questions

Who is PATEL DINESH V PH D?

Dinesh V. Patel, Ph.D., is the President and CEO of Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing peptide-based drug candidates. He has extensive experience in the biopharmaceutical industry and has held various leadership roles throughout his career.…

How many SEC Form 4 filings has PATEL DINESH V PH D submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has PATEL DINESH V PH D been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 15 open-market sales ($35.58M) across all tracked filings.

Where can I see all of PATEL DINESH V PH D's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live PATEL DINESH V PH D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.